Tosun Halil, Akinsal Emre Can, Bas Unsal, Sonmez Gokhan, Baydilli Numan, Demirci Deniz
Department of Urology, Erciyes University Faculty of Medicine, Kayseri, Turkey.
Department of Urology, Dr Ekrem Karakaya Hospital, Kayseri, Turkey.
Ther Clin Risk Manag. 2025 Aug 30;21:1309-1315. doi: 10.2147/TCRM.S534674. eCollection 2025.
Urinary incontinence (UI) is a common complication after radical prostatectomy (RP), adversely affecting patients' quality of life. This study aimed to evaluate the efficacy and safety of high-intensity focused electromagnetic (HIFEM) therapy as a non-invasive treatment for post-prostatectomy UI.
Twenty-seven men (mean age ± SD: 67.9 ± 3.4 years) with persistent UI after RP underwent six HIFEM sessions (28 min, twice weekly) using the BTL EMSELLA chair. Outcomes were assessed after the sixth session and at one-month follow-up. Primary endpoints were changes in International Consultation on Incontinence Questionnaire-Short Form (ICIQ-SF) scores and daily pad use.
Baseline mean ICIQ-SF score was 10.58 ± 4.15. This decreased to 5.43 ± 3.85 after treatment and to 4.16 ± 3.97 at one month, representing improvements of 53.1% and 60.6%, respectively (both p < 0.005). Daily pad use declined from baseline to 1.45 ± 1.54 after treatment and 1.13 ± 1.81 at follow-up (both p < 0.001). No adverse events were reported.
HIFEM therapy significantly improved UI severity and reduced pad dependence in men with post-prostatectomy incontinence, with effects sustained for at least one month and no observed side effects. These findings support HIFEM as a safe, non-invasive treatment option warranting further study in larger, long-term trials.
尿失禁（UI）是根治性前列腺切除术（RP）后的常见并发症，对患者的生活质量产生不利影响。本研究旨在评估高强度聚焦电磁（HIFEM）疗法作为前列腺切除术后尿失禁的非侵入性治疗方法的疗效和安全性。
27名RP术后持续性尿失禁的男性（平均年龄±标准差：67.9±3.4岁）使用BTL EMSELLA椅接受了6次HIFEM治疗（每次28分钟，每周两次）。在第六次治疗后和1个月随访时评估结果。主要终点是国际尿失禁咨询问卷简表（ICIQ-SF）评分和每日护垫使用情况的变化。
基线时ICIQ-SF平均评分为10.58±4.15。治疗后降至5.43±3.85，1个月时降至4.16±3.97，分别改善了53.1%和60.6%（均p<0.005）。每日护垫使用量从基线时的水平降至治疗后的1.45±1.54，随访时为1.13±1.81（均p<0.001）。未报告不良事件。
HIFEM疗法显著改善了前列腺切除术后尿失禁男性患者的尿失禁严重程度并减少了对护垫的依赖，效果持续至少1个月且未观察到副作用。这些发现支持HIFEM作为一种安全的非侵入性治疗选择，值得在更大规模的长期试验中进一步研究。
